H. J. Senn

561 total citations
8 papers, 406 citations indexed

About

H. J. Senn is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H. J. Senn has authored 8 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H. J. Senn's work include Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). H. J. Senn is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). H. J. Senn collaborates with scholars based in Switzerland and United States. H. J. Senn's co-authors include Jaw J. Wang, James F. Holland, Johannes Blom, Lucius F. Sinks, Engracio P. Cortes, Oliver Glidewell, Arthur Bank, Roland Sonntag, Kurt Brunner and Franco Cavalli and has published in prestigious journals such as New England Journal of Medicine, Clinical Orthopaedics and Related Research and Oncology.

In The Last Decade

H. J. Senn

7 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. J. Senn Switzerland	5	237	184	108	100	98	8	406
Andreja Zidar Slovenia	13	221 0.9×	178 1.0×	47 0.4×	172 1.7×	61 0.6×	16	463
Yoshinari Imajo Japan	10	196 0.8×	129 0.7×	52 0.5×	128 1.3×	46 0.5×	40	421
Stanford Cade United Kingdom	12	194 0.8×	210 1.1×	31 0.3×	128 1.3×	60 0.6×	26	446
Aylin Örgen Çallı Türkiye	12	101 0.4×	118 0.6×	74 0.7×	110 1.1×	40 0.4×	48	341
Ryan P. McCarthy United States	6	101 0.4×	124 0.7×	69 0.6×	219 2.2×	176 1.8×	8	409
Mary C. Bibro United States	12	54 0.2×	124 0.7×	84 0.8×	174 1.7×	89 0.9×	19	464
Priya Rao United States	10	175 0.7×	305 1.7×	77 0.7×	190 1.9×	20 0.2×	18	481
Ilaria Marcon Italy	7	290 1.2×	109 0.6×	42 0.4×	91 0.9×	31 0.3×	17	366
K. Khanfir Switzerland	11	214 0.9×	155 0.8×	27 0.3×	185 1.9×	62 0.6×	23	404
Hal E. Palmer United States	6	94 0.4×	177 1.0×	62 0.6×	54 0.5×	20 0.2×	9	302

Countries citing papers authored by H. J. Senn

Since Specialization

Citations

This map shows the geographic impact of H. J. Senn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. J. Senn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. J. Senn more than expected).

Fields of papers citing papers by H. J. Senn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. J. Senn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. J. Senn. The network helps show where H. J. Senn may publish in the future.

Co-authorship network of co-authors of H. J. Senn

This figure shows the co-authorship network connecting the top 25 collaborators of H. J. Senn. A scholar is included among the top collaborators of H. J. Senn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. J. Senn. H. J. Senn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Stiefel, Friedrich, R. Morant, & H. J. Senn. (2008). Asthenie bei Tumorkranken. DMW - Deutsche Medizinische Wochenschrift. 117(3). 107–111.

2.

Cortes, Engracio P., James F. Holland, Jaw J. Wang, et al.. (2005). THE CLASSIC: Amputation and Adriamycin in Primary Osteosarcoma. Clinical Orthopaedics and Related Research. &NA;(438). 5–8. 6 indexed citations

3.

Kessler, William R., et al.. (1990). Use of a Fully Implantable Drug Delivery System in the Treatment of Acute Leukemias and Disseminated Lymphomas. Oncology. 47(6). 449–455. 5 indexed citations

4.

Cavalli, Franco, et al.. (1978). VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.. PubMed. 62(3). 473–5. 147 indexed citations

5.

Cavalli, F, C. Sauter, H. J. Senn, & P. Alberto. (1976). [The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].. PubMed. 106(38). 1265–8. 1 indexed citations

6.

Jungi, W. F., et al.. (1975). [Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].. PubMed. 105(42). 1365–9. 6 indexed citations

7.

Cortes, Engracio P., James F. Holland, Jaw J. Wang, et al.. (1974). Amputation and Adriamycin in Primary Osteosarcoma. New England Journal of Medicine. 291(19). 998–1000. 238 indexed citations

8.

Mayr, Agnes, et al.. (1973). [Thrombocytosis in malignant tumors].. PubMed. 103(46). 1626–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact